UPDATED May 08, 2024
Discover large cap U.S. Pharmaceuticals & Biotech companies that are on the NYSE and NASDAQ. These Pharmaceuticals & Biotech Companies are organised by Market Cap.
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
WAT | US$323.80 | 2.5% | 18.9% | US$19.3b | US$324.39 | PE31.8x | E7.9% | n/a | ||
ILMN | US$110.62 | -11.3% | -47.2% | US$18.0b | US$156.10 | PS3.9x | E63.1% | n/a | ||
RPRX | US$27.99 | -0.3% | -17.3% | US$16.9b | US$45.88 | PE11.1x | E6.3% | 3.0% | ||
AVTR | US$24.28 | -0.6% | 18.0% | US$16.9b | US$27.77 | PE63.4x | E35.0% | n/a | ||
BGNE | US$164.44 | 5.1% | -32.9% | US$16.8b | US$267.97 | PS6.2x | E59.7% | n/a | ||
TEVA | US$15.74 | 12.6% | 88.5% | US$15.8b | US$15.74 | PS1.1x | E31.4% | 0% | ||
BMRN | US$81.83 | -1.8% | -14.0% | US$15.7b | US$110.02 | PE75.6x | E29.5% | n/a | ||
NBIX | US$139.02 | -0.6% | 42.1% | US$14.0b | US$157.81 | PE37.8x | E26.3% | n/a | ||
VTRS | US$11.81 | 1.5% | 23.1% | US$13.9b | US$12.46 | PE256.4x | E16.8% | 4.1% | ||
SRPT | US$132.58 | 1.3% | 9.3% | US$12.9b | US$165.89 | PE741.7x | E37.0% | n/a | ||
RVTY | US$102.83 | 0.2% | -17.4% | US$12.7b | US$123.61 | PE69.3x | E26.2% | 0.3% | ||
KRTX | US$329.83 | 3.3% | 80.7% | US$12.6b | US$326.92 | PS19238.9x | E60.1% | n/a | ||
MEDP | US$387.61 | -2.6% | 84.4% | US$12.4b | US$423.17 | PE38.4x | E13.8% | n/a | ||
INCY | US$53.51 | 1.1% | -16.3% | US$12.2b | US$73.35 | PE16.1x | E17.8% | n/a | ||
TECH | US$77.05 | 1.9% | -6.0% | US$12.1b | US$83.64 | PE59.8x | E14.9% | 0.4% | ||
CRL | US$235.29 | 2.3% | 20.2% | US$12.1b | US$270.67 | PE25.5x | E11.4% | n/a | ||
NTRA | US$95.66 | 1.6% | 86.8% | US$11.9b | US$103.38 | PS10.8x | E68.6% | n/a | ||
UTHR | US$261.09 | 2.3% | 23.0% | US$11.8b | US$292.74 | PE11x | E6.7% | n/a | ||
EXAS | US$59.48 | -0.9% | -24.5% | US$11.3b | US$89.48 | PS4.4x | E61.9% | n/a | ||
BRKR | US$73.70 | 5.2% | -3.7% | US$10.7b | US$85.70 | PE26.7x | E6.8% | 0.3% | ||
CTLT | US$56.20 | -0.2% | 64.4% | US$10.2b | US$63.50 | PS2.5x | E90.1% | n/a | ||
QGEN | US$42.94 | 0.3% | -8.5% | US$9.5b | US$50.19 | PE28.3x | E12.2% | n/a | ||
RGEN | US$165.50 | -0.5% | 8.6% | US$9.2b | US$204.16 | PE623.1x | E60.5% | n/a | ||
ROIV | US$11.21 | 0% | 21.5% | US$9.2b | US$16.11 | PE2.1x | E-52.0% | n/a |